Business Context and Reporting Period
Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2025
Business Overview: The Company operates three segments: Branded Products (customized merchandising and uniforms), Healthcare Apparel (scrubs and protective gear), and Contact Centers (outsourced business process services). The Company is an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $138,467 | $149,690 | $419,609 | $420,268 |
| Gross Margin | $53,078 (38.3%) | $60,546 (40.4%) | $158,845 (37.9%) | $166,618 (39.6%) |
| Net Income | $2,744 | $5,403 | $3,537 | $9,915 |
| Diluted EPS | $0.18 | $0.33 | $0.23 | $0.60 |
| EBITDA | $7,540 | $11,654 | $17,147 | $26,844 |
| Cash from Operations (9M) | $1,270 | $24,497 | - | - |
| Total Debt (Gross) | $100,000 | $86,035 | - | - |
| Cash & Equivalents | $16,651 | $18,766 | - | - |
Material Changes vs. Prior Period
- Revenue Decline: Q3 2025 net sales decreased 7.5% year-over-year, driven by declines across all segments. Branded Products fell 8.1% due to order timing and lower volume; Healthcare Apparel fell 4.6% due to volume decreases; Contact Centers fell 9.5% due to client attrition and macroeconomic headwinds.
- Profitability Compression: Net income dropped 49.2% in Q3 and 64.3% for the nine-month period. Gross margin rates declined across all segments (Branded Products: 34.8% vs 36.2%; Healthcare: 38.5% vs 41.8%; Contact Centers: 52.9% vs 54.9%).
- Cash Flow Deterioration: Operating cash flow for the nine months ended September 30, 2025, was $1.3 million, a significant decrease from $24.5 million in the prior year period. This was primarily due to a $10.5 million cash outflow for inventory purchases and increased receivables.
- Debt Utilization: Total debt increased to $100 million from $86 million, with the revolving credit facility balance rising to $40 million from $22 million.
Guidance, Outlook, and Risks
- Outlook: Management expects demand for Healthcare Apparel brands to continue providing growth opportunities. The Contact Centers segment faces continued macroeconomic headwinds with client downsizing outpacing new acquisitions.
- Tariff and Trade Risks: Significant new tariffs were imposed in 2025. Additionally, key trade agreements (AGOA, HOPE, HELP) expired on September 30, 2025. Failure to renew these could negatively impact costs and operations, particularly for sourcing in Haiti and Africa.
- Supply Chain: The Company relies heavily on China for fabrics and raw materials. Geopolitical instability and labor disputes in sourcing countries (Haiti, Vietnam, Bangladesh) pose risks to manufacturing continuity.
- Capital Allocation: The Company maintains a $17.5 million share repurchase program (approx. $12.3 million remaining as of Sept 30, 2025) and paid $6.7 million in dividends during the first nine months of 2025.
- Accounting Changes: The Company voluntarily moved its annual goodwill impairment testing date to August 31, 2025. No impairments were identified.
Investor Verification Checklist
- Inventory Build-up: Verify the rationale for the $10.5 million cash outflow for inventory and the increase in inventory balances ($105.7M vs $96.7M prior year) amidst declining sales.
- Tariff Impact: Assess the specific financial impact of the expired trade agreements (AGOA, HOPE, HELP) and new tariffs on the cost of goods sold for the fourth quarter and 2026.
- Contact Center Attrition: Monitor the rate of client attrition in the Contact Centers segment versus new customer acquisition to determine if the 9.5% Q3 decline is a trend.
- Liquidity Position: Review the sustainability of operating cash flows given the sharp drop from $24.5M to $1.3M and the increased reliance on the revolving credit facility.
- Debt Covenants: Confirm continued compliance with the fixed charge coverage ratio (1.25:1) and net leverage ratio (4.0:1) as debt levels have increased.